Oxgene

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Research & Development

Viral vector engineering to improve clinical performance and accelerate timelines for novel gene therapies

Viruses invade host cells and hijack their cellular machinery to direct the replication and transcription of their own genome. This makes them dangerous pathogens as well as ideal couriers to transport new DNA into a host cell and ensure that it’s transcribed, reports Dr Sophie Lutter, Scientific Communications and Marketing Manager, OXGENE
Manufacturing

WuXi AppTec completes acquisition of AAV manufacturer Oxgene

Since its founding in 2011, Oxgene has offered discovery and biomanufacturing solutions to the cell and gene therapy industries through novel technologies and contract research solutions
Research & Development

Oxgene introduces SLIM platform for antibody discovery

In a study published last month in the Journal of Biological Chemistry, Oxgene scientists used the SLIM platform to discover a panel of novel antibodies
Manufacturing

Oxgene introduces TESSA technology for AAV manufacture

It aims to address challenges such as the high cost of goods, and low packaging efficiency
Subscribe now